[研发][? 待核对]Northwest Biotherapeutics将在英国NHS年度肿瘤学大会发表DCVax®主题演讲

Northwest Biotherapeutics（OTCQB:NWBO）宣布，其首席技术官Marnix Bosch将于10月6日在英国NHS CancerCare年度肿瘤学大会发表特邀主题演讲，介绍DCVax®等树突状细胞癌症疫苗的个性化多靶点治疗路径。 公司：Northwest Biotherapeutics 相关资产：DCVax-L; DCVax-Direct 适应症：glioblastoma; inoperable solid tumor cancers; advanced ovarian cancer 阶段：Phase III (DCVax-L for GBM); Phase I (DCVax-Direct); MAA under review in UK 融资性质：不适用 来源：BioSpace · 新闻稿（https://www.biospace.com/press-releases/northwest-biotherapeutics-announces-keynote-presentation-on-harnessing-immunity-a-personalized-multi-target-approach-to-cancer-at-the-uk-national-health-service-annual-oncology-conference）